Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002907 stock hub

SHE/002907 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002907is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.7B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002907

In the news

Latest news · SHE/002907

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E99.4

P25 23.5P50 41.3P75 83.2

ROE2.5

P25 -0.9P50 4.1P75 8.8

ROIC2.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002907 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

CNY

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,439
Employees Change	55%
Employees Change Percent	3.97
Enterprise value	CNY 5.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100003308
Last refreshed	2026-05-10
Market cap	CNY 5.7B
Price	CNY 13.7
Price currency	CNY
Rev Per Employee	555,974.5x
Sector	Healthcare
Sic	2834
Symbol	she/002907
Website	https://www.pharscin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.01%
EV Earnings	89.82x
EV/EBIT	129.27x
EV/EBITDA	41.02x
EV/FCF	113.06x
EV/Sales	6.46x
FCF yield	0.8%
P/B ratio	3.3x
P/E ratio	99.43x
P/S ratio	7.15x
PE Ratio10 Y	77.23x
PE Ratio3 Y	104.67x
PE Ratio5 Y	89.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5%
EBITDA Margin	15.67%
FCF margin	5.71%
Gross margin	57.33%
Gross Profit	CNY 458.6M
Gross Profit Growth	3.1%
Gross Profit Growth Q	-10.27%
Gross Profit Growth3 Y	-0.43%
Gross Profit Growth5 Y	0.8%
Net Income	CNY 57.5M
Net Income Growth	-25.04%
Net Income Growth Q	-18.75%
Net Income Growth Years	0%
Net Income Growth3 Y	-16.6%
Net Income Growth5 Y	-14.76%
Pretax Margin	8.22%
Profit Margin	7.19%
Profit Per Employee	CNY 39,974
Profitable Years	13
ROA	1.25
Roa5y	2.28
ROCE	2.24
ROE	2.55
Roe5y	4.87
ROIC	2.36
Roic5y	5.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.82%
Cagr3y	-4.72%
Cagr5y	4.01%
Div CAGR3	-10.86%
Div CAGR5	3.38%
EPS Growth	-25
EPS Growth Q	-18.74
EPS Growth Years	0
EPS Growth3 Y	-17.28
EPS Growth5 Y	-15.44
FCF Growth	-71.41%
FCF Growth Q	-10.18%
FCF Growth3 Y	33.93%
FCF Growth5 Y	-10.34%
OCF Growth	-62.89%
OCF Growth Q	11.97%
OCF Growth3 Y	-5.42%
OCF Growth5 Y	-11.84%
Revenue Growth	1.87x
Revenue Growth Q	-11.34x
Revenue Growth Years	2x
Revenue Growth3 Y	1.3x
Revenue Growth5 Y	-3.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.4
Assets	CNY 2B
Cash	CNY 607M
Current Assets	CNY 1.2B
Current Liabilities	CNY 247.6M
Debt	CNY 40.9M
Debt EBITDA	CNY 0.32
Debt Equity	CNY 0.02
Debt FCF	CNY 0.9
Equity	CNY 1.7B
Interest Coverage	286.1
Liabilities	CNY 299M
Long Term Assets	CNY 876.6M
Long Term Liabilities	CNY 51.4M
Net Cash	CNY 566.1M
Net Cash By Market Cap	CNY 9.9
Net Cash Growth	3.43%
Net Debt EBITDA	CNY -4.52
Net Debt Equity	CNY -0.33
Net Debt FCF	CNY -12.39
Tangible Book Value	CNY 1.5B
Tangible Book Value Per Share	CNY 3.64
WACC	3.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.68
Inventory Turnover	2.64
Net Working Capital	CNY 341.9M
Quick ratio	3.7
Working Capital	CNY 910.9M
Working Capital Turnover	CNY 0.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.05%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.08
Dividend Years	8
Dividend Yield	0.55%
Last Dividend	CNY 0.04
Payout Ratio	61.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.82%
200-day SMA	15.88
3Y total return	-13.49%
50-day SMA	14.08
50-day SMA vs 200-day SMA	50under200
5Y total return	21.74%
All Time High	47.92
All Time High Change	-71.41%
All Time High Date	2018-01-19
All Time Low	5.98
All Time Low Change	129.1%
All Time Low Date	2017-10-20
ATR	0.37
Beta	-0.09
Beta1y	-0.4
Beta2y	0.11
Ch YTD	-7.49
High	13.78
High52	22.69
High52 Date	2025-06-03
High52ch	-39.62%
Low	13.6
Low52	12.84
Low52 Date	2026-03-23
Low52ch	6.7%
Ma50ch	-2.66%
Price vs 200-day SMA	-13.74%
RSI	42.48
RSI Monthly	44.9
RSI Weekly	38.62
Sharpe ratio	0.2x
Sortino ratio	0.51
Total Return	0.6%
Tr YTD	-7.49
Tr1m	-5.65%
Tr1w	0.07%
Tr3m	-9.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 40M
Operating Income Growth	-38.08
Operating Income Growth Q	-19.77
Operating Income Growth3 Y	-24.83
Operating Income Growth5 Y	-19.69
Operating margin	5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	122,243,951%
Net Borrowing	-159,612
Shares Insiders	31.68%
Shares Institutions	2.53%
Shares Out	417,596,314
Shares Qo Q	0.14%
Shares Yo Y	-0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 45.7M
Average Volume	3,901,919.55x
Bv Per Share	4.13
CAPEX	CNY -19.2M
Ch1m	-5.65
Ch1w	0.07
Ch1y	-4.26
Ch3m	-9.99
Ch3y	-14.85
Ch5y	19.13
Ch6m	-16.16
Change	0.66%
Change From Open	0.66
Close	13.61
Days Gap	0
Depreciation Amortization	85,409,656
Dollar Volume	31,462,050
Earnings Date	2026-04-24
EBIT	CNY 40M
EBITDA	CNY 125.4M
EPS	CNY 0.14
F Score	5
FCF	CNY 45.7M
FCF EV Yield	0.88x
FCF Per Share	CNY 0.11
Financing CF	-39,955,036
Fiscal Year End	December
Founded	1,996
Graham Number	3.57739
Graham Upside	-73.89
Income Tax	CNY 22M
Investing CF	-25,836,702
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Lynch Fair Value	CNY 0.69
Lynch Upside	-94.97
Ma150	15.27
Ma150ch	-10.27%
Ma20	14.04
Ma20ch	-2.44%
Net CF	-960,738
Next Earnings Date	2026-08-21
Open	13.61
P FCF Ratio	125.2
P OCF Ratio	88.21
Payment Date	2025-09-09
Position In Range	55.56
Ppne	484,065,113
Price Date	2026-05-08
Price EBITDA	CNY 45.63
Ptbv Ratio	3.76
Relative Volume	0.6x
Revenue	800,047,306x
Tax By Revenue	2.75x
Tax Rate	33.45%
Tr6m	-16.16%
Volume	2,296,500

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002907 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.07 annual per share

Payout ratio

+61.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.4%

0 consecutive years of growth

Total shareholder yield

+0.6%

Dividend yield + buyback yield combined

Performance

SHE/002907 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002907?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.5%

Share of float held by funds and institutions

Insider ownership

+31.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

SHE/002907 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.5

Neutral momentum band

Price vs 200-day MA

-13.7%

50/200-day relationship not available

Beta (5Y)

-0.09

Less volatile than the market

Sharpe ratio

0.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002907

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002907 stock rating?

she/002907 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002907 analysis?

The full report lives at /stocks/she/002907/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002907?

The latest report frames she/002907 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002907 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.